This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

Daiichi Sankyo UK Limited

Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire, SL9 0BG, UK
Telephone: +44 (0)1753 482 771
Medical Information Direct Line: +44 (0)1753 482 771
Medical Information e-mail: medinfo@daiichi-sankyo.co.uk
Customer Care direct line: +44 (0)1753 482 771
Medical Information Fax: +44 (0)1753 893 894
Out of Hours Telephone: +44 (0)1748 828 818

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 16/05/2013
PIL OLMETEC film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/05/2013 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - driving and using machines
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store
Updated on 24/01/2012 and displayed until 16/05/2013
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 10/11/2010 and displayed until 24/01/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/05/2010 and displayed until 10/11/2010
Reasons for adding or updating:
  • Addition of information on alternative format leaflets
Updated on 10/11/2009 and displayed until 05/05/2010
Reasons for adding or updating:
  • Change of contra-indications
  • Change to information about pregnancy or lactation
Updated on 17/06/2008 and displayed until 10/11/2009
Reasons for adding or updating:
  • Addition of joint PIL covering all presentations
  • Change due to user-testing of patient information
Updated on 21/05/2008 and displayed until 17/06/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 26/09/2007 and displayed until 21/05/2008
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 07/11/2006 and displayed until 26/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 26/09/2006 and displayed until 07/11/2006
Reasons for adding or updating:
  • Company name change or merger
Updated on 26/09/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Company name change or merger
Updated on 10/05/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/03/2004 and displayed until 10/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 27/05/2003 and displayed until 01/03/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics